Our study put forward for the first time that cynaropicrin can inhibit the proliferation of CRC and induce its apoptosis by targeting the LIFR/STATs axis in vitro and in vivo (Figure 7), suggesting that cynaropicrin is a potential natural product with anti-tumor efficacy. The gene discussed is LIFR; the disease is colorectal carcinoma.